Literature DB >> 15452303

Plasma exchange for severe optic neuritis: treatment of 10 patients.

K Ruprecht1, E Klinker, T Dintelmann, P Rieckmann, R Gold.   

Abstract

The authors reviewed a series of 10 consecutive patients treated with plasma exchange (PE) for acute, severe optic neuritis (ON) largely unresponsive to previous high-dose IV glucocorticosteroids. PE was associated with an improvement of visual acuity according to the study criteria in 7 of 10 patients. On follow-up, three of these patients continued to improve, two remained stable, and two had worsened again. PE may be beneficial as an escalating treatment in a subset of patients with severe ON. A controlled trial is warranted.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452303     DOI: 10.1212/01.wnl.0000138437.99046.6b

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  45 in total

1.  Plasmapheresis: are bigger studies necessarily better?

Authors:  Brian Weinshenker
Journal:  Nat Rev Neurol       Date:  2012-06-19       Impact factor: 42.937

2.  Successful treatment of a hypothalamic lesion in neuromyelitis optica by plasma exchange.

Authors:  Shohei Watanabe; Ichiro Nakashima; Isabelle Miyazawa; Tatsuro Misu; Yusei Shiga; Yoichi Nakagawa; Kazuo Fujihara; Yasuto Itoyama
Journal:  J Neurol       Date:  2007-03-14       Impact factor: 4.849

3.  Current issues in immunomodulatory treatment of multiple sclerosis--a practical approach.

Authors:  Martin Stangel; Ralf Gold; Achim Gass; Judith Haas; Stefan Jung; Wolfgang Elias; Uwe K Zettl
Journal:  J Neurol       Date:  2006-02       Impact factor: 4.849

4.  [Recent advances in the pathogenesis and immunotherapy of multiple sclerosis].

Authors:  R Gold; P Rieckmann
Journal:  Nervenarzt       Date:  2007-09       Impact factor: 1.214

5.  Plasma exchange therapy for steroid-refractory superimposed relapses in secondary progressive multiple sclerosis.

Authors:  Ralf A Linker; Andrew Chan; Martin Sommer; Michael Koziolek; Gerhard-Anton Müller; Walter Paulus; Ralf Gold
Journal:  J Neurol       Date:  2007-08-16       Impact factor: 4.849

6.  Reversible central neurogenic hyperventilation in an awake patient with multiple sclerosis.

Authors:  M Takahashi; T Tsunemi; T Miyayosi; H Mizusawa
Journal:  J Neurol       Date:  2007-11-21       Impact factor: 4.849

Review 7.  Corticosteroids and plasma exchange in multiple sclerosis.

Authors:  Hayretin Tumani
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

8.  Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations.

Authors:  H Wiendl; K V Toyka; P Rieckmann; R Gold; H-P Hartung; R Hohlfeld
Journal:  J Neurol       Date:  2008-10-29       Impact factor: 4.849

9.  [Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses: clinical experience with 16 patients].

Authors:  S Schilling; R A Linker; F B König; M Koziolek; M Bähr; G A Müller; W Paulus; J Gärtner; W Brück; A Chan; R Gold
Journal:  Nervenarzt       Date:  2006-04       Impact factor: 1.214

10.  Management of acute exacerbations in multiple sclerosis.

Authors:  Daniel Ontaneda; Alex D Rae-Grant
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.